From the therapists One of the hardest parts of this conversation is that people with eating disorders are often not believed or not taken seriously when they raise concerns with prescribing providers
No human trials as of June 2026
A retrospective analysis of more than 110,000 women between the ages of 45 and 80 found that those who took GLP-1 medications were about 30% less likely to develop breast cancer than those who did not take GLP-1 medications, according to research presented today at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting (Abstract 10506) by Elizabeth McDonald, MD, PhD, a professor of Radiology in the University of Pennsylvania Perelman School of Medicine and a practicing breast radiologist at Penns Abramson Cancer Center
High power view of brown pigment inside of macrophages at the lamina propria
Kelley added that other issues, including the duration of medication availability through TrumpRx, need to be resolved
Its transparent manufacturing, trusted ingredient sourcing, and growing community of positive user feedback make it a standout in a market that's often saturated with hype and underwhelming results